March 24, 2025
TOPLINE: Belimumab combined with standard therapy demonstrated significant improvements in mucocutaneous symptoms in patients with systemic lupus erythematosus (SLE) compared with placebo with standard therapy, with […]
March 21, 2025
TOPLINE: Sustained clinical remission for at least 3 years in patients with systemic lupus erythematosus (SLE) and active lupus nephritis significantly reduced the probability of developing […]
March 20, 2025
For juvenile idiopathic arthritis (JIA), 2024 was marked by both successes and heightened controversy. There were new US Food and Drug Administration (FDA) warnings for DRESS […]
March 20, 2025
TOPLINE: The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid […]
March 19, 2025
TOPLINE: A meta-analysis of 16 observational studies found no significant association between vaccination exposure and risk for rheumatoid arthritis (RA). Short-term follow-up data (< 1 year) […]
March 18, 2025
For people with complex chronic diseases such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and dysautonomia, a clinician’s inadvertently hurtful language can compound suffering and […]
March 18, 2025
Hip and knee replacements are increasingly predictable and durable, with a better patient experience and a “declining revision burden,” as demand increases from both an aging […]
March 17, 2025
Knee osteoarthritis (KOA) appears to be among a long list of conditions improved by glucagon-like peptide 1 receptor agonists (GLP-1 RAs), but data suggesting possible adverse […]
March 17, 2025
TOPLINE: Approximately one quarter of patients with psoriatic arthritis (PsA) exhibited axial involvement (axial PsA). Enthesitis, inflammatory bowel disease, and HLA-B27 positivity were associated with an […]